Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)

HKG:1501 Revenue

Shanghai INT Medical Instruments had revenue of 596.06M CNY in the half year ending June 30, 2026, with 51.93% growth. This brings the company's total for the last twelve months to 1.20B, up 30.38% year-over-year. In the year 2025, Shanghai INT Medical Instruments had annual revenue of 1.07B with 25.06% growth. That makes Shanghai INT Medical Instruments the 18,357th largest company in the world by revenue and 1,075th in Hong Kong.

• Revenue (ttm): 1.20B CNY
• Revenue Growth: +30.38%
• P/S Ratio: 4.57
• Revenue / Employee: 550.67K CNY
• Employees: 2,180
• Market Cap: 6.33B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue by Segment

By Segment

Chart

• Cardiovascular Interventional Business 876.93M 74.2%
• ALL Others 304.17M 25.8%

By Geography

Chart

• Mainland China 809.00M 75.9%
• Other countries and regions 151.43M 14.2%
• Europe 58.99M 5.5%
• The United States 46.06M 4.3%

Fiscal year ended Dec 31, 2025 See the full HKG:1501 breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.07B	213.52M	25.06%
Dec 31, 2024	851.95M	99.12M	13.17%
Dec 31, 2023	752.84M	166.95M	28.50%
Dec 31, 2022	585.88M	121.21M	26.08%
Dec 31, 2021	464.68M	106.25M	29.64%

Data Source: S&P Global Market Intelligence Last updated: Sep 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 20, 2026

Data Sources Report a data error